Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The International Longshoremen’s Association is set to strike if a new contract can’t be reached with the United States Maritime Alliance.
The insurance industry needs to be careful when using AI, or else AI black boxes could render consumers uninsurable without any explanation.
Walmart will soon roll out an option that would allow consumers to pay for online orders directly via instant bank account transfers.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
On Monday, BP announced it will put its US onshore wind power business, estimated to be worth about $2 billion, on the market.
A Labour Party official said he’d like to see legislation that heavily impacts imports of Chinese textiles — a potential problem for Shein.
Days after industrial workers in its Pacific Northwest plants voted to approve a labor strike, Boeing instituted a hiring freeze.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Auction house Christie’s has agreed to buy Gooding and Company, a classic auto auction house, to expand its luxury offerings.
McDonald’s announced that its $5 summer meal deal, which was only supposed to last through June, will now be extended into December.
Moderna walked a tightrope trying to convince shareholders it can both develop a new portfolio of drugs and keep costs down in the process.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.